Theoretically, a new perspective for future treatments of mutant insulin-related diabetes might be achieved by briefly stimulating mTORC1, given that the stimulation is performed during the neonatal period (Balboa et al., 2018). This evidence concerns the gene INS and diabetes mellitus.